Take Your Trading To The Next Level. Get Started Here!

FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product

May 31, 2024 Comments Off

The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product.